These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

836 related items for PubMed ID: 23747045

  • 1. Accelerated tau pathology with synaptic and neuronal loss in a novel triple transgenic mouse model of Alzheimer's disease.
    Saul A, Sprenger F, Bayer TA, Wirths O.
    Neurobiol Aging; 2013 Nov; 34(11):2564-73. PubMed ID: 23747045
    [Abstract] [Full Text] [Related]

  • 2. Increased misfolding and truncation of tau in APP/PS1/tau transgenic mice compared to mutant tau mice.
    Héraud C, Goufak D, Ando K, Leroy K, Suain V, Yilmaz Z, De Decker R, Authelet M, Laporte V, Octave JN, Brion JP.
    Neurobiol Dis; 2014 Feb; 62():100-12. PubMed ID: 24076100
    [Abstract] [Full Text] [Related]

  • 3. Neurofibrillary tangle formation by introducing wild-type human tau into APP transgenic mice.
    Umeda T, Maekawa S, Kimura T, Takashima A, Tomiyama T, Mori H.
    Acta Neuropathol; 2014 May; 127(5):685-98. PubMed ID: 24531886
    [Abstract] [Full Text] [Related]

  • 4. Neuropathology of mice carrying mutant APP(swe) and/or PS1(M146L) transgenes: alterations in the p75(NTR) cholinergic basal forebrain septohippocampal pathway.
    Jaffar S, Counts SE, Ma SY, Dadko E, Gordon MN, Morgan D, Mufson EJ.
    Exp Neurol; 2001 Aug; 170(2):227-43. PubMed ID: 11476589
    [Abstract] [Full Text] [Related]

  • 5. Human tau increases amyloid β plaque size but not amyloid β-mediated synapse loss in a novel mouse model of Alzheimer's disease.
    Jackson RJ, Rudinskiy N, Herrmann AG, Croft S, Kim JM, Petrova V, Ramos-Rodriguez JJ, Pitstick R, Wegmann S, Garcia-Alloza M, Carlson GA, Hyman BT, Spires-Jones TL.
    Eur J Neurosci; 2016 Dec; 44(12):3056-3066. PubMed ID: 27748574
    [Abstract] [Full Text] [Related]

  • 6. Effects of the superoxide dismutase/catalase mimetic EUK-207 in a mouse model of Alzheimer's disease: protection against and interruption of progression of amyloid and tau pathology and cognitive decline.
    Clausen A, Xu X, Bi X, Baudry M.
    J Alzheimers Dis; 2012 Dec; 30(1):183-208. PubMed ID: 22406441
    [Abstract] [Full Text] [Related]

  • 7. Tauopathy contributes to synaptic and cognitive deficits in a murine model for Alzheimer's disease.
    Stancu IC, Ris L, Vasconcelos B, Marinangeli C, Goeminne L, Laporte V, Haylani LE, Couturier J, Schakman O, Gailly P, Pierrot N, Kienlen-Campard P, Octave JN, Dewachter I.
    FASEB J; 2014 Jun; 28(6):2620-31. PubMed ID: 24604080
    [Abstract] [Full Text] [Related]

  • 8. Truncated tau at D421 is associated with neurodegeneration and tangle formation in the brain of Alzheimer transgenic models.
    Zhang Q, Zhang X, Sun A.
    Acta Neuropathol; 2009 Jun; 117(6):687-97. PubMed ID: 19190923
    [Abstract] [Full Text] [Related]

  • 9. Sex Dimorphism Profile of Alzheimer's Disease-Type Pathologies in an APP/PS1 Mouse Model.
    Jiao SS, Bu XL, Liu YH, Zhu C, Wang QH, Shen LL, Liu CH, Wang YR, Yao XQ, Wang YJ.
    Neurotox Res; 2016 Feb; 29(2):256-66. PubMed ID: 26707129
    [Abstract] [Full Text] [Related]

  • 10. Early neuronal loss and axonal/presynaptic damage is associated with accelerated amyloid-β accumulation in AβPP/PS1 Alzheimer's disease mice subiculum.
    Trujillo-Estrada L, Dávila JC, Sánchez-Mejias E, Sánchez-Varo R, Gomez-Arboledas A, Vizuete M, Vitorica J, Gutiérrez A.
    J Alzheimers Dis; 2014 Feb; 42(2):521-41. PubMed ID: 24927710
    [Abstract] [Full Text] [Related]

  • 11. Accelerated amyloid deposition, neurofibrillary degeneration and neuronal loss in double mutant APP/tau transgenic mice.
    Ribé EM, Pérez M, Puig B, Gich I, Lim F, Cuadrado M, Sesma T, Catena S, Sánchez B, Nieto M, Gómez-Ramos P, Morán MA, Cabodevilla F, Samaranch L, Ortiz L, Pérez A, Ferrer I, Avila J, Gómez-Isla T.
    Neurobiol Dis; 2005 Dec; 20(3):814-22. PubMed ID: 16125396
    [Abstract] [Full Text] [Related]

  • 12. Alzheimer's disease pathological lesions activate the spleen tyrosine kinase.
    Schweig JE, Yao H, Beaulieu-Abdelahad D, Ait-Ghezala G, Mouzon B, Crawford F, Mullan M, Paris D.
    Acta Neuropathol Commun; 2017 Sep 06; 5(1):69. PubMed ID: 28877763
    [Abstract] [Full Text] [Related]

  • 13. Synaptic dysfunction in hippocampus of transgenic mouse models of Alzheimer's disease: a multi-electrode array study.
    Chong SA, Benilova I, Shaban H, De Strooper B, Devijver H, Moechars D, Eberle W, Bartic C, Van Leuven F, Callewaert G.
    Neurobiol Dis; 2011 Dec 06; 44(3):284-91. PubMed ID: 21807097
    [Abstract] [Full Text] [Related]

  • 14. Hypercholesterolemia accelerates intraneuronal accumulation of Aβ oligomers resulting in memory impairment in Alzheimer's disease model mice.
    Umeda T, Tomiyama T, Kitajima E, Idomoto T, Nomura S, Lambert MP, Klein WL, Mori H.
    Life Sci; 2012 Dec 10; 91(23-24):1169-76. PubMed ID: 22273754
    [Abstract] [Full Text] [Related]

  • 15. Alzheimer's disease-like tau neuropathology leads to memory deficits and loss of functional synapses in a novel mutated tau transgenic mouse without any motor deficits.
    Schindowski K, Bretteville A, Leroy K, Bégard S, Brion JP, Hamdane M, Buée L.
    Am J Pathol; 2006 Aug 10; 169(2):599-616. PubMed ID: 16877359
    [Abstract] [Full Text] [Related]

  • 16. Quantitative proteomic analysis of the hippocampus in the 5XFAD mouse model at early stages of Alzheimer's disease pathology.
    Hong I, Kang T, Yoo Y, Park R, Lee J, Lee S, Kim J, Song B, Kim SY, Moon M, Yun KN, Kim JY, Mook-Jung I, Park YM, Choi S.
    J Alzheimers Dis; 2013 Aug 10; 36(2):321-34. PubMed ID: 23603400
    [Abstract] [Full Text] [Related]

  • 17. Alzheimer's disease and amyloid: culprit or coincidence?
    Skaper SD.
    Int Rev Neurobiol; 2012 Aug 10; 102():277-316. PubMed ID: 22748834
    [Abstract] [Full Text] [Related]

  • 18. Indirubin-3'-monoxime rescues spatial memory deficits and attenuates beta-amyloid-associated neuropathology in a mouse model of Alzheimer's disease.
    Ding Y, Qiao A, Fan GH.
    Neurobiol Dis; 2010 Aug 10; 39(2):156-68. PubMed ID: 20381617
    [Abstract] [Full Text] [Related]

  • 19. Dispersible amyloid β-protein oligomers, protofibrils, and fibrils represent diffusible but not soluble aggregates: their role in neurodegeneration in amyloid precursor protein (APP) transgenic mice.
    Rijal Upadhaya A, Capetillo-Zarate E, Kosterin I, Abramowski D, Kumar S, Yamaguchi H, Walter J, Fändrich M, Staufenbiel M, Thal DR.
    Neurobiol Aging; 2012 Nov 10; 33(11):2641-60. PubMed ID: 22305478
    [Abstract] [Full Text] [Related]

  • 20. Calretinin interneurons are early targets of extracellular amyloid-beta pathology in PS1/AbetaPP Alzheimer mice hippocampus.
    Baglietto-Vargas D, Moreno-Gonzalez I, Sanchez-Varo R, Jimenez S, Trujillo-Estrada L, Sanchez-Mejias E, Torres M, Romero-Acebal M, Ruano D, Vizuete M, Vitorica J, Gutierrez A.
    J Alzheimers Dis; 2010 Nov 10; 21(1):119-32. PubMed ID: 20413859
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 42.